Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ProAssurance Completes Acquisition Of Eastern Insurance

RELATED NEWS
Trade PRA now with 

ProAssurance Corp. (PRA: Quote) said Thursday that it has completed its acquisition of Eastern Insurance Holdings, Inc.

Eastern's shareholders approved the deal at a special meeting on December 27.

Under terms of the deal announced in September, Eastern becomes a wholly-owned subsidiary of ProAssurance through an all cash deal that valued Eastern at $24.50 per share or $205 million.

Eastern Insurance President Michael Boguski and the Eastern senior executive team have entered into long-term contracts in conjunction with the transaction. Eastern will continue to operate from its corporate office in Lancaster, Pennsylvania and will maintain all existing regional and satellite office locations.

Click here to receive FREE breaking news email alerts for ProAssurance Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.